255 results on '"Forman, Stephen J"'
Search Results
2. PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial
3. Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial
4. Author Correction: Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial
5. A platform to deliver single and bi-specific Cas9/guide RNA to perturb genes in vitro and in vivo
6. Impact of spliceosome mutation on outcomes of myelodysplastic syndrome and chronic myelomonocytic leukemia patients undergoing allogeneic hematopoietic cell transplantation
7. Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma
8. Yttrium-90 anti-CD25 BEAM conditioning for autologous hematopoietic cell transplantation in Peripheral T-cell lymphoma
9. Analysis of polyfunctionality for enhanced BAFF-R CAR T-cell therapy for hematologic malignancies
10. Nonsignaling extracellular spacer regulates tumor antigen selectivity of CAR T cells
11. Ex-vivo CS1-OKT3 dual specific bivalent antibody-armed effector T cells mediate cellular immunity against multiple myeloma
12. Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting
13. Donor-derived CD19-targeted chimeric antigen receptor T cells in adult transplant recipients with relapsed/refractory acute lymphoblastic leukemia
14. Isoform-specific knockdown of long and intermediate prolactin receptors interferes with evolution of B-cell neoplasms
15. The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study
16. Feasibility of implementing a supervised telehealth exercise intervention in frail survivors of hematopoietic cell transplantation: a pilot randomized trial
17. Dexamethasone potentiates chimeric antigen receptor T cell persistence and function by enhancing IL-7Rα expression
18. Risky health behaviors and subsequent late mortality after blood or marrow transplantation: a BMTSS report
19. Prediction of Coronary Heart Disease Events in Blood or Marrow Transplantation Recipients
20. Association of pre-transplant vancomycin resistant enterococcus colonization status on long-term outcomes of allogeneic-hematopoietic cell transplantation
21. Risk of COVID-19 infection in long-term survivors of blood or marrow transplantation: a BMTSS report
22. Post-Transplantation Sinusoidal Obstruction Syndrome in Adult Patients with B Cell Acute Lymphoblastic Leukemia Treated with Pretransplantation Inotuzumab
23. Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial
24. Total Body Irradiation and Fludarabine with Post-Transplantation Cyclophosphamide for Mismatched Related or Unrelated Donor Hematopoietic Cell Transplantation
25. Consolidation with First and Second Allogeneic Transplants in Adults with Relapsed/Refractory B-ALL Following Response to CD19CAR T Cell Therapy
26. Genome-wide variants and polygenic risk scores for cognitive impairment following blood or marrow transplantation
27. Impact of COVID-19 pandemic on global unrelated stem cell donations in 2020—Report from World Marrow Donor Association
28. Cost-effectiveness of polatuzumab vedotin combined with chemoimmunotherapy in untreated diffuse large B-cell lymphoma
29. Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma
30. Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALL
31. Spatial organization of heterogeneous immunotherapy target antigen expression in high-grade glioma
32. Total marrow and lymphoid irradiation as conditioning in haploidentical transplant with posttransplant cyclophosphamide
33. Response-adapted anti-PD-1–based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE
34. CD19/BAFF-R dual-targeted CAR T cells for the treatment of mixed antigen-negative variants of acute lymphoblastic leukemia
35. Tacrolimus initial steady state level in post-transplant cyclophosphamide-based GvHD prophylaxis regimens
36. Conditioning intensity and probability of live birth after blood or marrow transplantation, a BMTSS report
37. Peritransplantation ruxolitinib administration is safe and effective in patients with myelofibrosis: a pilot open-label study
38. IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cells.
39. Impact of Antifungal Prophylaxis Continuation or Discontinuation After Allogeneic Hematopoietic Cell Transplant on the Incidence of Invasive Mold Infection.
40. Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome‐positive acute lymphoblastic leukemia.
41. Body composition and late‐occurring chronic health conditions after autologous stem cell transplantation for lymphoma.
42. Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T‐cell therapy in Philadelphia chromosome‐positive acute lymphoblastic leukaemia.
43. Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide
44. Development of CMV-CD19 bi-specific CAR T cells with post-infusion in vivo boost using an anti-CMV vaccine
45. CD19-directed CAR T-cell therapy for treatment of primary CNS lymphoma
46. Treatment of allosensitized patients receiving allogeneic transplantation
47. Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model
48. Use of high-dose mesna and hyperhydration leads to lower incidence of hemorrhagic cystitis after posttransplant cyclophosphamide-based allogeneic transplantation
49. Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis
50. Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.